Vikas Goyal serves as Executive at Spero Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Vikas Goyal has executed 12 insider transactions totaling $11.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 1, 2021 involved transacting 87,764 shares valued at $5.3M.
Vikas Goyal currently holds 1,000 shares of Spero Therapeutics, Inc. (SPRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vikas Goyal has been a net buyer of SPRO stock. They have purchased $11.1M and sold $0 worth of shares.
Vikas Goyal's most recent insider trade was on Apr 1, 2021, when they sold 87,764 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted
| $70.00 |
| Discretionary |
| Jul 21, 2020 | PAND | $0 | Conversion | 7,044 | $N/A | Discretionary |
| Jul 21, 2020 | PAND | $26.1K | Purchase | 1,450 | $18.00 | Discretionary |
| Jul 1, 2019 | MORF | $5.0M | Purchase | 333,333 | $15.00 | Discretionary |
| Jul 1, 2019 | MORF | $0 | Conversion | 830,489 | $N/A | Discretionary |
| Jul 1, 2019 | MORF | $0 | Conversion | 1,469,950 | $N/A | Discretionary |
| Nov 6, 2017 | SPRO | $0 | Conversion | 244,147 | $N/A | Discretionary |
| Nov 6, 2017 | SPRO | $0 | Conversion | 246,272 | $N/A | Discretionary |
| Nov 6, 2017 | SPRO | $0 | Conversion | 328,992 | $N/A | Discretionary |
| Nov 6, 2017 | SPRO | $0 | Conversion | 606,024 | $N/A | Discretionary |
| Nov 6, 2017 | SPRO | $6.0M | Purchase | 428,571 | $14.00 | Discretionary |